Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2026-01-18 @ 1:38 PM
Study NCT ID:
NCT02409368
Status:
COMPLETED
Last Update Posted:
2022-11-14
First Post:
2015-04-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-27
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-01
First Submit QC Date:
None
Study First Post Date:
2015-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-03-31
Results First Submit QC Date:
None
Results First Post Date:
2021-07-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-17
Last Update Post Date:
2022-11-14
Last Update Post Date Type:
ACTUAL